Check out our most popular compounded medications! Get Started
Dashboard
Formulas

Fluticasone Propionate 880 Mcg/10 ml Oral Suspension

FDA-approved generic
Dose form
Suspension
Active ingredients
Fluticasone Propionate
For prescribers
Prescription details
RxThis formula
Dose formSee below
Quantity____
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription detailsOrder form
Controlled substance: e-prescribe (EPCS) from your EHR. Faxed and phoned prescriptions cannot be accepted for this preparation.
Send it from your EHR, or fax to (401) 284-4506. How to e-prescribe this formula
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Fill my prescription
Fill my prescription
Requires a prescription from your own provider. Bayview is a pharmacy and does not prescribe.
Save 15% on every refill when you enroll in Automatic Refills
Ships within 1 to 2 business days after pharmacist verification
HSA and FSA eligible
Check if we ship to your state
No prescription yet?

Get a sheet with everything your doctor needs to prescribe this and send it to Bayview.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.

For prescribersSign in for prescription details and order forms.
Compounded preparations are prepared by Bayview pursuant to a prescription for an individual patient. They are not FDA-approved and have not been evaluated by FDA for safety or effectiveness.
Fluticasone Propionate
Suspension
6427079ea6432495e0518b48
Service area

Can we ship this formula to your state?

Bayview fills prescriptions for patients in Connecticut, Florida, Maine, Massachusetts, New Hampshire, New Jersey, Pennsylvania and Rhode Island. New York patients are served on a limited basis while nonresident pharmacy registration is pending.

Check your state

Available in

Tap a state to check it.

Our current service area

Currently licensed Limited basis, registration pending Not available for this formula Not currently licensed

Select a state on the map or use the checker.

Prepared to a prescriber's order for one patient. Not FDA-approved.

This formulation

This is a compounded suspension containing fluticasone propionate, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.

FDA product listings

These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.

FDA-approved products containing fluticasone are listed in spray, powder, aerosol, cream, ointment and lotion forms. No finished fluticasone product of any kind is listed in suspension form.

Storage category and dating

Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.

Sources

Why prescribers order this

Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.

Fluticasone propionate is a corticosteroid that compounding pharmacies prepare by prescription in several dosage forms.

About this ingredient

Fluticasone propionate is a synthetic corticosteroid with local anti-inflammatory and vasoconstrictive effects; it reduces inflammatory cells such as eosinophils, mast cells and macrophages. Manufactured fluticasone propionate products include an HFA inhalation aerosol, FDA-approved for maintenance treatment of asthma as prophylactic therapy in patients 4 years and older and not for acute bronchospasm; a prescription nasal spray approved for perennial nonallergic rhinitis; nonprescription nasal sprays for hay fever and allergy symptoms; and a medium-potency cream approved for the inflammatory and itchy signs of corticosteroid-responsive skin conditions. MedlinePlus notes that Xhance nasal spray treats chronic rhinosinusitis with or without nasal polyps. A prescriber might order fluticasone propionate compounded for a strength, vehicle or dosage form that is not manufactured, or one free of a specific allergen. Compounded preparations are not FDA-approved and require a prescription.

Safety and interactions

The inhaled product is contraindicated as primary treatment of status asthmaticus or other acute asthma episodes and in people allergic to its ingredients. Its warnings include oral thrush, immunosuppression and infection risk, adrenal problems when switching from oral steroids, reduced bone density, slowed growth in children, glaucoma and cataracts, and paradoxical bronchospasm. The label does not recommend use with strong CYP3A4 inhibitors such as ritonavir or clarithromycin, because fluticasone is a CYP3A4 substrate. The cream may be used with caution in children 3 months and older; applying a potent steroid to large areas or under occlusion can suppress the adrenal (HPA) axis. MedlinePlus gives similar growth and eye warnings for the nasal spray. LactMed says inhaled amounts reaching milk are probably too small to affect an infant, and advises keeping the infant's skin away from treated areas with topical use. Talk to your prescriber or pharmacist about side effects.

Fluticasone propionate acts locally; per the HFA label, oral systemic bioavailability is negligible (under 1%) because of incomplete absorption and presystemic metabolism, while most drug delivered to the lung is absorbed systemically. Plasma protein binding averages 99%, volume of distribution averages 4.2 L/kg, and terminal elimination half-life after intravenous dosing is about 7.8 hours. CYP3A4 forms the only circulating metabolite, a 17β-carboxylic acid derivative with less glucocorticoid receptor affinity; under 5% of a radiolabeled oral dose appears in urine as metabolites. Labeled indications: HFA inhaler for asthma maintenance in patients 4 and older; prescription nasal spray for perennial nonallergic rhinitis in patients 4 and older; cream for corticosteroid-responsive dermatoses, with safety beyond 4 weeks not established in children. StatPearls lists off-label use for COPD and eosinophilic esophagitis; these are not FDA-approved indications for the products cited. Dosing is per prescriber. Monitor growth in children, eye health, oral candidiasis with inhaled use, and HPA axis suppression with extensive topical use; the cream label names ACTH stimulation, morning plasma cortisol and urinary free cortisol tests.

Sources

Using and storing

How it is used

Shake the bottle well before every dose so the medication is evenly mixed. Measure with the oral syringe or dosing cup provided, using the milliliter markings, and never a kitchen spoon. Take it by mouth as your label directs. Rinse the syringe after use and recap the bottle.

Storing it

Water-based suspensions are aqueous preparations. Under USP <795>, a preserved suspension usually carries a beyond-use date of up to 35 days at room temperature or refrigerated; an unpreserved one is refrigerated for up to 14 days. Oil-based suspensions are nonaqueous and may carry up to 90 days. Your label states storage and the beyond-use date. Keep out of reach of children and discard after that date.

Sources

Prescribing and ordering FAQs

Formula Information

A small arrow pointing down

Drug Interactions

A small arrow pointing down

How Does it Work

A small arrow pointing down

Frequently Asked Questions

A small arrow pointing down

About this compounded preparation

This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.

A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
For prescribers

How to e-prescribe this formula

Controlled substance: e-prescribe only (EPCS). Faxed, phoned, and handwritten prescriptions cannot be filled. Rhode Island law (R.I. Gen. Laws § 21-28-3.18) requires Schedule II to V prescriptions to be transmitted electronically.
1

Find Bayview in your EHR's pharmacy directory

Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.

NCPDP4106882NPI1750455143Address3844 Post Rd, Warwick, RI 02886Phone(401) 284-4505Fax(401) 284-4506
2

Enter the formula as a compound

Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.

Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.

3

Copy the prescription details

RxFormula name
Dose formDose form
Quantity________
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription details

Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.

4

Send it

Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.

Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.

Do not use Notes to Pharmacy for the formula. Some EHRs keep that field internal and never transmit it. A prescription that arrives without the formula is delayed while we call your office.

Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.

Fluticasone Propionate 880 Mcg/10 ml Oral Suspension
Suspension
30 mL
controlled

Take orally

Twice daily